SMTL ID : 1v3v.1

Crystal structure of leukotriene B4 12-hydroxydehydrogenase/15-oxo-prostaglandin 13-reductase complexed with NADP and 15-oxo-PGE2

Coordinates

PDB Format

Method

X-RAY DIFFRACTION 2.00 Å

Oligo State

homo-dimer

Ligands

6 x CL: CHLORIDE ION(Non-functional Binders)

CL.1: 3 residues within 4Å: Chain A: E.319, N.322, A.324 Ligand excluded by PLIP CL.2: 4 residues within 4Å: Chain A: H.16, F.17, S.58, K.59 Ligand excluded by PLIP CL.3: 4 residues within 4Å: Chain A: F.17, G.19, R.55, N.250 Ligand excluded by PLIP CL.6: 4 residues within 4Å: Chain B: H.16, F.17, S.58, K.59 Ligand excluded by PLIP CL.7: 3 residues within 4Å: Chain B: E.319, N.322, A.324 Ligand excluded by PLIP CL.8: 6 residues within 4Å: Chain B: F.17, Q.18, G.19, R.55, K.59, N.250 Ligand excluded by PLIP

2 x NAP: NADP NICOTINAMIDE-ADENINE-DINUCLEOTIDE PHOSPHATE(Non-covalent)

NAP.4: 28 residues within 4Å: Chain A: P.52, M.128, T.132, A.153, G.156, A.157, V.158, A.177, G.178, K.182, Y.197, N.221, V.222, C.243, G.244, A.245, I.246, S.247, Y.249, F.274, I.275, V.276, M.320, L.321, G.323, N.325 Chain B: I.265 Ligands: 5OP.5 26 PLIP interactions: 26 interactions with chain A Hydrophobic interactions: A:T.132, A:V.276 Hydrogen bonds: A:A.157, A:V.158, A:G.178, A:K.182, A:Y.197, A:N.221, A:C.243, A:I.246, A:Y.249, A:V.276, A:N.325, A:N.325 Water bridges: A:D.51, A:D.51, A:Y.53, A:G.156, A:G.159, A:Y.197, A:K.198, A:I.246, A:S.247, A:S.247 Salt bridges: A:K.182, A:K.198 NAP.9: 28 residues within 4Å: Chain A: I.265 Chain B: P.52, M.128, T.132, A.153, G.156, A.157, V.158, A.177, G.178, K.182, Y.197, N.221, V.222, C.243, G.244, A.245, I.246, S.247, Y.249, F.274, I.275, V.276, M.320, L.321, G.323, N.325 Ligands: 5OP.10 23 PLIP interactions: 23 interactions with chain B Hydrophobic interactions: B:T.132, B:V.276 Hydrogen bonds: B:A.157, B:V.158, B:G.178, B:K.182, B:N.221, B:C.243, B:A.245, B:I.246, B:V.276, B:N.325, B:N.325 Water bridges: B:Y.53, B:G.156, B:G.159, B:Y.197, B:Y.197, B:I.246, B:S.247, B:S.247, B:K.328 Salt bridges: B:K.182

2 x 5OP: (5E,13E)-11-HYDROXY-9,15-DIOXOPROSTA-5,13-DIEN-1-OIC ACID(Non-covalent)

5OP.5: 9 residues within 4Å: Chain A: Y.53, C.243, Y.249, Y.277 Chain B: P.261, E.262, I.265, Y.266 Ligands: NAP.4 6 PLIP interactions: 2 interactions with chain A, 4 interactions with chain B Hydrophobic interactions: A:Y.277, B:P.261, B:E.262, B:I.265, B:Y.266 Hydrogen bonds: A:Y.53 5OP.10: 10 residues within 4Å: Chain A: P.261, E.262, I.265, Y.266 Chain B: Y.53, I.56, C.243, Y.249, Y.277 Ligands: NAP.9 8 PLIP interactions: 4 interactions with chain A, 4 interactions with chain B Hydrophobic interactions: A:P.261, A:E.262, A:I.265, A:Y.266, B:Y.53, B:I.56, B:Y.277 Hydrogen bonds: B:Y.53

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Hori, T. et al., Structural basis of leukotriene B4 12-hydroxydehydrogenase/15-Oxo-prostaglandin 13-reductase catalytic mechanism and a possible Src homology 3 domain binding loop. J.Biol.Chem. (2004)

Release Date

2004-07-13

Peptides

leukotriene b4 12-hydroxydehydrogenase/prostaglandin 15-keto reductase: AB

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

B
B

leukotriene b4 12-hydroxydehydrogenase/prostaglandin 15-keto reductase

Related Entries With Identical Sequence